Clinical Trial Update: Non-invasive Prenatal Diagnostic Validation Study

View source ↗

Summary

The study completed validation of a non-invasive prenatal diagnostic test for fetal chromosomal abnormalities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q11 Deletion Syndrome
• Down Syndrome
• Edwards Syndrome
• Klinefelter Syndrome
• Patau Syndrome
• Triple-x Syndrome
• Turner Syndrome
• Xyy Syndrome

Snippet

Sponsor: Natera, Inc. | Conditions: Chromosome 13 Aneuploidy, Chromosome 18 Aneuploidy | Status: COMPLETED